Eli Lilly Total Liabilities 2012-2026 | LLY

Eli Lilly total liabilities for the quarter ending March 31, 2026 were $85.941B, a 33.36% increase year-over-year.

  • Eli Lilly total liabilities for 2025 were $85.941B, a 33.36% increase from 2024.
  • Eli Lilly total liabilities for 2024 were $64.443B, a 21.26% increase from 2023.
  • Eli Lilly total liabilities for 2023 were $53.143B, a 37.27% increase from 2022.

Eli Lilly Total Liabilities 2012-2026 | LLY

  • Eli Lilly total liabilities for 2025 were $85.941B, a 33.36% increase from 2024.
  • Eli Lilly total liabilities for 2024 were $64.443B, a 21.26% increase from 2023.
  • Eli Lilly total liabilities for 2023 were $53.143B, a 37.27% increase from 2022.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B